InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
59%
T+90 mean return
+8.6%
Across 22 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Baynes Roy D., Director. Insider active across 4 companies, notably Travere Therapeutics, Inc.. Aggregated, 39 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €286k. History available since 14 May 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations39 total
1,571 sharesCommon StockSEC:0001680739-26-000015:0
75 sharesCommon StockSEC:0001680739-26-000015:1
4,500 sharesCommon StockSEC:0001680739-26-000014:0
4,500 sharesCommon StockSEC:0001680739-26-000014:1
4,000 shares0Common StockSEC:0001680739-26-000012:0
83 sharesCommon StockSEC:0001680739-26-000006:0
10,000 shares@ US$26.520.0058% mcap24.1% of flowCommon StockSEC:0001680739-26-000003:0
10,000 shares@ US$33.000.0072% mcap30.0% of flowCommon StockSEC:0001680739-26-000003:1
108 sharesCommon StockSEC:0001415889-25-020514:0
6,500 shares0Common StockSEC:0001415889-25-013496:0
116 sharesCommon StockSEC:0001415889-25-011550:0
10,000 shares@ US$17.4417.6% of flowCommon StockSEC:0001415889-25-003529:0
92 sharesCommon StockSEC:0001415889-25-003068:0
16,000 shares@ US$17.5028.2% of flowCommon StockSEC:0001415889-25-002003:0
22,000 shares@ US$22.8386.7% of flowCommon StockSEC:0001415889-24-027020:0
124 sharesCommon StockSEC:0001415889-24-025713:0
143 sharesCommon StockSEC:0001415889-24-020382:0
2,964 sharesCommon StockSEC:0001415889-24-019063:0
6,500 shares0Common StockSEC:0001415889-24-012844:0
169 sharesCommon StockSEC:0001415889-24-011829:0
215 shares@ US$63.792.3% of flowCommon StockSEC:0001415889-24-001998:0
322 shares@ US$42.602.4% of flowCommon StockSEC:0001415889-23-014635:0
264 shares@ US$48.482.1% of flowCommon StockSEC:0001415889-23-011685:0
2,750 sharesCommon StockSEC:0001415889-23-010848:0
3,534 sharesCommon StockSEC:0001415889-23-008882:0
25 of 39 declarations
About Baynes Roy D.
Roy D. Baynes is a Board Member at Travere Therapeutics, Inc., Natera, Inc., and Atara Biotherapeutics, Inc. He plays a crucial role in the strategic direction of these companies, contributing to their growth and development.
